115 related articles for article (PubMed ID: 24090307)
1. Capecitabine in the treatment of esophageal and gastric cancers.
Popa EC; Shah MA
Expert Opin Investig Drugs; 2013 Dec; 22(12):1645-57. PubMed ID: 24090307
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine: a review.
Walko CM; Lindley C
Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604
[TBL] [Abstract][Full Text] [Related]
3. Review of capecitabine as oral treatment of gastric, gastroesophageal, and esophageal cancers.
Ajani J
Cancer; 2006 Jul; 107(2):221-31. PubMed ID: 16770784
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of capecitabine in gastric cancer.
Comella P; Franco L; Casaretti R; de Portu S; Menditto E
Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950
[TBL] [Abstract][Full Text] [Related]
5. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.
Rich TA; Shepard RC; Mosley ST
J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine in gastric cancer.
Bang YJ
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1791-806. PubMed ID: 22117147
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine in gastric cancer.
Okines A; Chau I; Cunningham D
Drugs Today (Barc); 2008 Aug; 44(8):629-40. PubMed ID: 18846273
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine: in advanced gastric or oesophagogastric cancer.
Dhillon S; Scott LJ
Drugs; 2007; 67(4):601-10. PubMed ID: 17352519
[TBL] [Abstract][Full Text] [Related]
9. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer.
Iqbal S; Lenz HJ
Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325
[TBL] [Abstract][Full Text] [Related]
10. Contemporary issues and the potential uses of capecitabine in metastatic breast cancer.
Barrett-Lee P; Bidard FC; Pierga JY
Cancer Treat Rev; 2009 Nov; 35(7):582-9. PubMed ID: 19632050
[TBL] [Abstract][Full Text] [Related]
11. Capecitabine in the treatment of colorectal cancer.
O'Neill VJ; Cassidy J
Future Oncol; 2005 Apr; 1(2):183-90. PubMed ID: 16555988
[TBL] [Abstract][Full Text] [Related]
12. Capecitabine with radiation is an effective adjuvant therapy in gastric cancers.
Tham CK; Choo SP; Poon DY; Toh HC; Ong SY; Tan SH; Wang ML; Foo KF
World J Gastroenterol; 2010 Aug; 16(29):3709-15. PubMed ID: 20677345
[TBL] [Abstract][Full Text] [Related]
13. [Economic evaluation of capecitabine use as first line treatment in patients with advanced gastric carcinoma in Portugal].
Macedo A; Pereira C; Gonçalves J; Sousa C
Acta Med Port; 2009; 22(6):827-32. PubMed ID: 20350467
[TBL] [Abstract][Full Text] [Related]
14. Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumours.
Sternberg CN; Reichardt P; Holland M
Eur J Oncol Nurs; 2004; 8 Suppl 1():S4-15. PubMed ID: 15341878
[TBL] [Abstract][Full Text] [Related]
15. Xeloda in Adjuvant Colon Cancer Therapy (X-ACT) trial: overview of efficacy, safety, and cost-effectiveness.
Twelves CJ
Clin Colorectal Cancer; 2006 Nov; 6(4):278-87. PubMed ID: 17241512
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and therapeutic efficacy of capecitabine: focus on breast and colorectal cancer.
Aprile G; Mazzer M; Moroso S; Puglisi F
Anticancer Drugs; 2009 Apr; 20(4):217-29. PubMed ID: 19247178
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
[TBL] [Abstract][Full Text] [Related]
18. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer.
Patel PA
Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine in advanced gastric or oesophagogastric cancer: a viewpoint by Yoon-Koo Kang.
Kang YK
Drugs; 2007; 67(4):611-2. PubMed ID: 17352520
[No Abstract] [Full Text] [Related]
20. Update on capecitabine in colorectal cancer.
Schmoll HJ; Arnold D
Oncologist; 2006 Oct; 11(9):1003-9. PubMed ID: 17030642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
